Mahamaya Lifesciences Limited, established on May 7, 2002, specializes in the manufacturing and supply of pesticide formulations to both Indian and multinational agrochemical companies. Initially focusing on the import and regulatory approval of pesticide molecules not produced domestically, the company has expanded into comprehensive manufacturing and marketing operations. Its portfolio includes bulk formulations and value-added branded products. In December 2021, the company established a manufacturing plant in Dahej, Gujarat, which supports both domestic sales through a robust dealer network across several Indian states and exports to countries like the Dominican Republic, Turkey, Egypt, and the UAE.
The company is actively diversifying into sustainable agriculture by introducing Norwegian seaweed extract-based bio-stimulants and expanding its range of bio-products to align with the growing demand for eco-friendly solutions. Additionally, Mahamaya Lifesciences established a UAE subsidiary, Mahamaya Lifesciences FZE, in 2017 to bolster its international trade operations, particularly for imports and exports.
With a focus on innovation and market expansion, the company plans to raise capital through an IPO comprising 61,78,800 equity shares, including a fresh issue of 56,38,800 shares and an offer for sale of 5,40,000 shares. This growth strategy underlines its commitment to scaling production, expanding its bio-product portfolio, and increasing its global footprint in the agrochemical industry.
